<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>BACKGROUND: The continuous exposure of esophageal epithelium to refluxate may induce ectopic expression of bile-responsive genes and contribute to the development of <z:hpo ids='HP_0100580'>Barrett's esophagus</z:hpo> (BE) and esophageal <z:mp ids='MP_0009308'>adenocarcinoma</z:mp> </plain></SENT>
<SENT sid="1" pm="."><plain>In <z:mpath ids='MPATH_458'>normal</z:mpath> <z:mp ids='MP_0001532'>physiology</z:mp> of the gut and liver, the nuclear receptor <z:chebi fb="0" ids="8386">Pregnane</z:chebi> Ã— Receptor (PXR) is an important factor in the detoxification of <z:chebi fb="0" ids="35703">xenobiotics</z:chebi> and <z:chebi fb="0" ids="3098">bile acid</z:chebi> homeostasis </plain></SENT>
<SENT sid="2" pm="."><plain>This study aimed to investigate the expression and genetic variation of PXR in reflux <z:hpo ids='HP_0100633'>esophagitis</z:hpo> (RE), <z:hpo ids='HP_0100580'>Barrett's esophagus</z:hpo> (BE) and esophageal <z:mp ids='MP_0009308'>adenocarcinoma</z:mp> </plain></SENT>
<SENT sid="3" pm="."><plain>METHODS: PXR <z:chebi fb="2" ids="33699">mRNA</z:chebi> levels and protein expression were determined in biopsies from patients with <z:mp ids='MP_0009308'>adenocarcinoma</z:mp>, BE, or RE, and healthy controls </plain></SENT>
<SENT sid="4" pm="."><plain>Esophageal cell lines were stimulated with <z:chebi fb="0" ids="16325">lithocholic acid</z:chebi> and <z:chebi fb="0" ids="28077">rifampicin</z:chebi> </plain></SENT>
<SENT sid="5" pm="."><plain>PXR polymorphisms 25385C/T, 7635A/G, and 8055C/T were genotyped in 249 BE patients, 233 RE patients, and 201 controls matched for age and gender </plain></SENT>
<SENT sid="6" pm="."><plain>RESULTS: PXR <z:chebi fb="2" ids="33699">mRNA</z:chebi> levels were significantly higher in <z:mp ids='MP_0009308'>adenocarcinoma</z:mp> tissue and columnar Barrett's epithelium, compared to squamous epithelium of these BE patients (P&lt;0.001), and RE patients (P=0.003) </plain></SENT>
<SENT sid="7" pm="."><plain>Immunohistochemical staining of PXR showed predominantly cytoplasmic expression in BE tissue, whereas nuclear expression was found in <z:mp ids='MP_0009308'>adenocarcinoma</z:mp> tissue </plain></SENT>
<SENT sid="8" pm="."><plain>In cell lines, stimulation with <z:chebi fb="0" ids="16325">lithocholic acid</z:chebi> did not increase PXR <z:chebi fb="2" ids="33699">mRNA</z:chebi> levels, but did induce nuclear translocation of PXR protein </plain></SENT>
<SENT sid="9" pm="."><plain>Genotyping of the PXR 7635A/G polymorphism revealed that the G allele was significantly more prevalent in BE than in RE or controls (P=0.037) </plain></SENT>
<SENT sid="10" pm="."><plain>CONCLUSIONS: PXR expresses in BE and <z:mp ids='MP_0009308'>adenocarcinoma</z:mp> tissue, and showed nuclear localization in <z:mp ids='MP_0009308'>adenocarcinoma</z:mp> tissue </plain></SENT>
<SENT sid="11" pm="."><plain>Upon stimulation with <z:chebi fb="0" ids="16325">lithocholic acid</z:chebi>, PXR translocates to the nuclei of OE19 <z:mp ids='MP_0009308'>adenocarcinoma</z:mp> cells </plain></SENT>
<SENT sid="12" pm="."><plain>Together with the observed association of a PXR polymorphism and BE, this data implies that PXR may have a function in prediction and treatment of <z:e sem="disease" ids="C0014852" disease_type="Disease or Syndrome" abbrv="">esophageal disease</z:e> </plain></SENT>
</text></document>